Emmdara 50mg Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Fludarabine (50mg)
Overview Emmdara 50mg Injection
Obinutuzumab 50mg injection treats chronic lymphocytic leukemia (CLL), a type of blood cancer. Its use may extend to other conditions as directed by a physician, sometimes in conjunction with other drugs as part of a combined chemotherapy regimen. Administered intravenously under medical supervision, the dosage and frequency are determined individually by your doctor, varying based on your condition and potentially changing over time. Precise adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse reactions. While benefits may not be immediately apparent (taking several weeks or months), discontinuation should only occur under medical guidance. Frequent side effects include nausea, vomiting, diarrhea, headache, fatigue, fever, and cough. The medication can lower blood cell counts (white and red blood cells), increasing infection risk. Regular blood tests monitoring blood cell levels, along with heart, liver function, and uric acid, are essential. Prior to treatment, inform your doctor of any heart, liver, or kidney conditions, and all medications you're taking, particularly those for infections; many drugs can interact with this one. This medication is contraindicated during pregnancy or breastfeeding; effective contraception is recommended for both partners throughout treatment.
Primary Ingredients of Emmdara 50mg Injection
No text provided to rephrase.
Uses of Emmdara 50mg Injection
Chronic lymphocytic leukemia, a type of blood malignancy.
Major Benefits of Emmdara 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Emmdara 50mg Injection:
- Increased risk of infection
- Vomiting
- Weakness
- Nausea
- Fatigue
- Fever
- Decreased blood cells (red cells, white cells, and platelets)
- Diarrhea
- Cough
How to use Emmdara 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Emmdara 50mg Injection works:
The injectable drug Emmdara 50mg is a cancer treatment that inhibits the replication of cancerous blood cells' genetic material (DNA and RNA). This action curbs cancer cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Emmdara 50mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Emmdara 50mg Injection during pregnancy is contraindicated due to confirmed fetal risk. Exceptions may be made in extreme circumstances where the potential benefits outweigh the known hazards, at the sole discretion of the prescribing physician. Physician consultation is essential.
Breast feedingUNSAFE
Administering Emmdara 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
The administration of Emmdara 50mg Injection may induce adverse reactions impacting driving aptitude. Fatigue, weakness, visual disturbances, confusion, agitation, or seizures have been reported in some patients receiving Emmdara 50mg Injection, potentially compromising their ability to operate a vehicle.
KidneyCAUTION
For individuals with impaired kidney function, Emmdara 50mg Injection requires careful administration and may necessitate dosage modification. A physician's consultation is advised. The use of Emmdara 50mg Injection is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Emmdara 50mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Emmdara 50mg Injection :
NA
Facts to Know About Emmdara 50mg Injection
| Label | Value |
|---|---|
| Chemical Category | Purine Nucleoside Analogs |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Metabolic Inhibitors |
3,018 People bought this recently